BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10971375)

  • 1. Pneumocystis carinii pneumonia in a patient with pyoderma gangrenosum treated with cyclosporin.
    De Silva BD; Buxton PK
    Br J Dermatol; 2000 Sep; 143(3):683-4. PubMed ID: 10971375
    [No Abstract]   [Full Text] [Related]  

  • 2. Pyoderma gangrenosum associated with Takayasu's arteritis responding to cyclosporin.
    Fearfield LA; Ross JR; Farrell AM; Costello C; Bunker CB; Staughton RC
    Br J Dermatol; 1999 Aug; 141(2):339-43. PubMed ID: 10468813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The simultaneous treatment of inflammatory bowel diseases and associated pyoderma gangrenosum with oral cyclosporin A.
    Capella GL; Frigerio E; Fracchiolla C; Altomare G
    Scand J Gastroenterol; 1999 Feb; 34(2):220-1. PubMed ID: 10192206
    [No Abstract]   [Full Text] [Related]  

  • 4. Pyoderma gangrenosum successfully treated with cyclosporin A.
    V'lckova-Laskoska MT; Laskoski DS; Caca-Biljanovska NG; Darkoska JS
    Adv Exp Med Biol; 1999; 455():541-5. PubMed ID: 10599396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bullous pyoderma gangrenosum secondary to underlying multiple myeloma: treated with ciclosporin.
    Razmi T M; Muhammed H; Handa S; Malhotra P; Sharma S; Saikia UN; Aggarwal R; Dogra S
    Clin Exp Dermatol; 2019 Mar; 44(2):e13-e15. PubMed ID: 30294832
    [No Abstract]   [Full Text] [Related]  

  • 6. Two cases of bullous pyoderma gangrenosum complicated by Epstein-Barr virus infection.
    Zhou Y; Chen W; Zhang X; Huang F; Wang D
    Eur J Dermatol; 2018 Jun; 28(3):370-371. PubMed ID: 29952293
    [No Abstract]   [Full Text] [Related]  

  • 7. Pyoderma gangrenosum of the scalp treated with cyclosporine A.
    Patrone P; Bragadin G; De Francesco V; Frattasio A; Stinco G
    Int J Dermatol; 2002 Dec; 41(12):916-8. PubMed ID: 12492988
    [No Abstract]   [Full Text] [Related]  

  • 8. Pneumocystis carinii pneumonia in a patient on immunosuppressive drugs for pyoderma gangrenosum.
    McGarry H; McLelland J
    Br J Dermatol; 2002 Jul; 147(1):192-3. PubMed ID: 12100210
    [No Abstract]   [Full Text] [Related]  

  • 9. Pyoderma gangrenosum in a patient with primary cutaneous peripheral T-cell lymphoma, not otherwise specified.
    Patsatsi A; Koletsa T; Sotiriadis D; Kartsios C; Papaconstantinou A; Kostopoulos I
    Eur J Dermatol; 2012; 22(6):792-3. PubMed ID: 23228951
    [No Abstract]   [Full Text] [Related]  

  • 10. Peripheral regional aseptic neutrophilic lymphadenopathy associated with pyoderma gangrenosum.
    Al-Niaimi F; Cox NH
    Br J Dermatol; 2009 Nov; 161(5):1206-7. PubMed ID: 19678821
    [No Abstract]   [Full Text] [Related]  

  • 11. Pyoderma gangrenosum as a cause of spontaneous vulvovaginal ulceration.
    Langeland T; Rokkones E
    Acta Obstet Gynecol Scand; 2004 Dec; 83(12):1220-1. PubMed ID: 15548161
    [No Abstract]   [Full Text] [Related]  

  • 12. [Severe pyoderma associated with rheumatoid arthritis].
    Renner R; Sticherling M
    Med Klin (Munich); 2008 Apr; 103(4):251-3. PubMed ID: 18484211
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporin A in the treatment of rheumatoid associated pyoderma gangrenosum.
    Nisar M; Gawkrodger D; Bax D
    Br J Rheumatol; 1995 Feb; 34(2):182. PubMed ID: 7704469
    [No Abstract]   [Full Text] [Related]  

  • 14. [What is your diagnosis? Pyoderma gangrenosum].
    Wieler B; Vorburger D; Lindenmann N
    Praxis (Bern 1994); 2009 Dec; 98(25):1497-8. PubMed ID: 20013685
    [No Abstract]   [Full Text] [Related]  

  • 15. Pyoderma gangrenosum in a patient with rheumatoid arthritis responding to treatment with cyclosporin A.
    Hughes JR; Smith E; Higgins EM; Berry H; du Vivier AW
    Br J Rheumatol; 1994 Jul; 33(7):680-1. PubMed ID: 8019800
    [No Abstract]   [Full Text] [Related]  

  • 16. Guess what! Malignant pyoderma responding to cyclosporine.
    Cardinali C; Giomi B; Caproni M; Fabbri P
    Eur J Dermatol; 2001; 11(6):595-6. PubMed ID: 11701420
    [No Abstract]   [Full Text] [Related]  

  • 17. Image Gallery: Pyoderma gangrenosum in a patient with myelodysplastic syndrome treated with azacitidine.
    Pardo Pastor J; Redondo Capafons S; March López P; Nicolás Picó J; Pineda A; Martí JM
    Br J Dermatol; 2017 Sep; 177(3):e68. PubMed ID: 28940271
    [No Abstract]   [Full Text] [Related]  

  • 18. Pyoderma gangrenosum: clinical characteristics, associated diseases, and responses to treatment in a retrospective cohort study of 31 patients.
    Vacas AS; Torre AC; Bollea-Garlatti ML; Warley F; Galimberti RL
    Int J Dermatol; 2017 Apr; 56(4):386-391. PubMed ID: 28295267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyoderma gangrenosum masquerading as dermatitis artefacta.
    Harries MJ; McMullen E; Griffiths CE
    Arch Dermatol; 2006 Nov; 142(11):1509-10. PubMed ID: 17116850
    [No Abstract]   [Full Text] [Related]  

  • 20. Pyoderma gangrenosum in childhood--the importance of early recognition.
    Bell H; Parslew R
    Eur J Pediatr; 2002 Jan; 161(1):65-6. PubMed ID: 11808884
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.